About Dompé Investigational Medication Overview REPAVID-22 Clinical Trial RESPIRATIO Clinical Trial Resources Contact the
Study Team
home-small

Pulmonary
Clinical Trials

Contact the study team

Contact usmedinfo@dompe.com for any questions.

This site is intended for healthcare professionals only.

 

© 2024 Dompé farmaceutici S.p.A. All rights reserved. Reparixin is an investigational drug that is not approved for use in any country and is currently being investigated in clinical trials.